Of note, E2F3 amplification, a frequent event in UC, and ERBB2 S310F mutation, mostly prevalent in UC (at a rate of 3.64%), further suggest an aggressive urothelial origin as opposed to SCLC being metastatic in the bladder [20,21,22]. Here, ERBB2 is linked to small cell lung carcinoma.